-
FairJourney Biologics Joins Forces with Iontas
contractpharma
May 14, 2020
FairJourney Biologics and Iontas, two Clinical Research Organizations (CROs) in antibody discovery services, have combined their operations to create an international platform and provide their industry leading services to global biopharma.
-
Junshi, Lilly to Co-develop Antibody Therapies for COVID-19
contractpharma
May 13, 2020
Multiple neutralizing antibodies have been engineered, with the lead asset poised to enter clinical testing in the second quarter.
-
Sorrento, Mount Sinai to Develop COVI-Shield Antibody Therapy
contractpharma
May 13, 2020
Sorrento Therapeutics Inc. and Mount Sinai Health System have agreed to join forces in the investigation and development of an antibody cocktail (COVI-Shield) to potentially treat COVID-19.
-
Regeneron says COVID-19 antibody cocktail may be available by fall
expresspharma
May 06, 2020
The company is one of the many drugmakers looking to tackle COVID-19, caused by the new coronavirus that has no current approved treatment or vaccine and has claimed over 250,000 lives worldwide.
-
Researchers identify antibody with activity against SARS-CoV-2 in lab
pharmaceutical-technology
May 05, 2020
Researchers at Utrecht University and Erasmus Medical Center in the Netherlands, in alliance with China-based firm Harbour BioMed, have identified a fully human monoclonal antibody with activity against the novel coronavirus, SARS-CoV-2.
-
ProteoGenix Announces a COVID-19 Antibody Library
americanpharmaceuticalreview
May 04, 2020
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
-
Genalyte Launches High-Speed COVID-19 Antibody Test
contractpharma
April 29, 2020
First instrument-based, rapid test uses multi-antigen approach; U.S. FDA EUA submitted.
-
Novel antibody delivery method could improve precision medicine
europeanpharmaceuticalreview
April 24, 2020
Scientists have developed a protocol for encapsulating antibodies in an ultrasound-sensitive drug carrier for targeted drug delivery.
-
Abbott Launches Third COVID-19 Test
contractpharma
April 16, 2020
Begins shipping April 16 and intends to distribute 4 million tests in April, ramping to 20 million in the U.S. per month in June and beyond.
-
Celltrion identifies antibody candidates against Covid-19
pharmaceutical-technology
April 15, 2020
Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.